Albert Llado

Barcelona, CT, Spain

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 151 publications

Neuropsychological Profile and Cognitive Trajectories of Patients With Biomarker Evidence of Alzheimer Disease or Dementia With Lewy bodies.

Neuropsychological Profile and Cognitive Trajectories of Patients With Biomarker Evidence of Alzheimer Disease or Dementia With Lewy bodies.

Journal: Neurology

Published: July 01, 2026

Prognostic Determinants of Presentation and Outcome in Anti-IgLON5 Disease.

Prognostic Determinants of Presentation and Outcome in Anti-IgLON5 Disease.

Journal: Neurology(R) neuroimmunology & neuroinflammation

Published: June 04, 2026

Age-stratified associations between severe mental illness, dementia, and ischemic stroke: findings from the PADRIS-PRESTO cohort.

Age-stratified associations between severe mental illness, dementia, and ischemic stroke: findings from the PADRIS-PRESTO cohort.

Journal: European neuropsychopharmacology : the journal of the European College of Neuropsychopharmacology

Published: February 19, 2026

Improving the clinical trial landscape for patients with atypical variants of Alzheimer's disease: a call to action.

Improving the clinical trial landscape for patients with atypical variants of Alzheimer's disease: a call to action.

Journal: Alzheimer's & dementia : the journal of the Alzheimer's Association

Published: February 03, 2026

Improving the clinical trial landscape for patients with atypical variants of Alzheimer's disease: a call to action.

Improving the clinical trial landscape for patients with atypical variants of Alzheimer's disease: a call to action.

Journal: Alzheimer's & dementia : the journal of the Alzheimer's Association

Published: February 03, 2026

Atrophy signature for alpha-synuclein copathology in Alzheimer's disease.

Atrophy signature for alpha-synuclein copathology in Alzheimer's disease.

Journal: Alzheimer's & dementia (Amsterdam, Netherlands)

Published: January 26, 2026

Predictive Ability of Plasma p-tau217 for β-Amyloid Status: A Prospective Multicenter Study.

Predictive Ability of Plasma p-tau217 for β-Amyloid Status: A Prospective Multicenter Study.

Journal: Annals of clinical and translational neurology

Published: January 26, 2026

Proteomic analysis in Alzheimer's disease and other dementias: a focus on sex-specific differences.

Proteomic analysis in Alzheimer's disease and other dementias: a focus on sex-specific differences.

Journal: Alzheimer's research & therapy

Published: January 20, 2026

Synucleinopathy-like clinical features and biologically defined synuclein seeding in PSP-Parkinsonism: an imperfect match.

Synucleinopathy-like clinical features and biologically defined synuclein seeding in PSP-Parkinsonism: an imperfect match.

Journal: NPJ Parkinson's disease

Published: December 29, 2025

Relationship between locus coeruleus and slow-wave sleep in aging and Alzheimer's disease.

Relationship between locus coeruleus and slow-wave sleep in aging and Alzheimer's disease.

Journal: Alzheimer's & dementia : the journal of the Alzheimer's Association

Published: November 17, 2025

Appropriate use recommendations of the Spanish Society of Neurology's Behavioural Neurology and Dementia Study Group on anti-amyloid antibodies in the treatment of Alzheimer disease.

Appropriate use recommendations of the Spanish Society of Neurology's Behavioural Neurology and Dementia Study Group on anti-amyloid antibodies in the treatment of Alzheimer disease.

Journal: Neurologia

Published: November 10, 2025

Plasma p-Tau217 and GFAP predict widespread cognitive decline in Alzheimer's disease.

Plasma p-Tau217 and GFAP predict widespread cognitive decline in Alzheimer's disease.

Journal: Journal of neurology

Published: October 09, 2025

Showing 1-12 of 151

Last Updated: 09/26/2026